Viz.ai partners with Cleerly in the name of AI-based CCTA evaluations

Two healthcare technology companies known for their advanced artificial intelligence (AI) capabilities, San Francisco-based Viz.ai and Denver-based Cleerly, have announced a new partnership designed to boost care for heart patients. 

As a result of this new arrangement, Cleerly’s AI algorithms for evaluating coronary CT angiography (CCTA) images will now be made available as part of the Viz.ai One platform. Viz.ai has been working to expand its offerings for cardiologists, adding algorithms trained to evaluate electrocardiograms, echocardiograms and more to Viz.ai One.

Cleerly’s algorithms were trained to automatically identify signs of atherosclerosis in CCTA results using medical images from more than 40,000 patients. Providers are then alerted when a troubling sign is identified so they can spring to action and start developing a treatment plan. 

“This partnership exemplifies our continued commitment to collaborating with industry leading companies, ensuring quick access to important patient data, and ultimately improving clinical impact with Viz.ai One,” Chris Mansi, MD, CEO and co-founder at Viz.ai, said in a statement. “We are proud to partner with Cleerly to enhance our comprehensive AI platform, tailoring it to cardiovascular needs, enabling cardiologists and care teams to deliver optimal care to more patients most efficiently.”

"This partnership marks a significant step forward in our mission to revolutionize heart disease diagnostics and treatment, improving the detection of actionable heart health issues and transforming the landscape of cardiovascular care," added Cleerly CEO James K. Min, MD

More than 1,600 hospitals and health systems use the Viz.ai One platform to enhance the care they provide on a regular basis. The platform connects a patient’s entire care team—referring physicians, specialists and others—so that everyone remains on the same page throughout the care process. It can also be integrated into a variety of electronic health records and PACS.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."